Schilddrüsenhormonwirkung – jenseits klassischer Konzepte

Zusammenfassung

Schilddrüsenhormone spielen eine entscheidende Rolle in fast allen Organsystemen. Liegt eine Schilddrüsenfunktionsstörung vor, kann das pathophysiologische Konsequenzen in vielen Organsystemen haben. Die Einschätzung einer normalen oder pathologischen Schilddrüsenfunktion erfolgt biochemisch über die Bestimmung von TSH und der Schilddrüsenhormone T3 und T4, wobei es internationale Debatten darüber gibt, welcher Normbereich für TSH zu verwenden ist. Dies hat jedoch Auswirkungen auf die Behandlung der Patienten. Es klagen leider häufig Patienten, deren Schilddrüsenfunktion laborchemisch richtig eingestellt ist, über diverse Beschwerden. Mit den kürzlich identifizierten Schilddrüsenhormontransportern sowie der Identifizierung von neuen Schilddrüsenhormonmetaboliten, könnte eine bessere Einschätzung des individuellen Schilddrüsenhormonstatus möglich sein. Um die Zusammenhänge und Auswirkungen dieser neuen Parameter besser verstehen und für den Patienten nutzen zu können, wurde das durch die Deutsche Forschungsgemeinschaft initiierte Schwerpunktprogramm Thyroid Trans Act ins Leben gerufen. Der Fokus dieses interdisziplinären Forschungsverbundes ist die Bearbeitung der Frage nach dem gesunden Schilddrüsen-Status und der besseren Einschätzung eines pathologischen Schilddrüsenstatus mit dem übergeordneten Ziel einer besseren und adäquaten Behandlung der Patienten sowie der Prävention von Schilddrüsenhomon-abhängigen Erkrankungen.

Abstract

Thyroid hormones are of crucial importance for the function of nearly all organ systems. In case of dysfunction of thyroid hormone production and function many organ systems may be affected. The estimation of normal thyroid function is based on determination of TSH and the thyroid hormones T3 and T4. However, international conventions about the normal TSH range are still lacking which bears consequences for patient`s treatment. Hence not unexpected, many patients complain although their thyroid hormone status is in the normal range by clinical estimation. Here, more precise parameters are needed for a better definition of the healthy thyroid status of an individual. Recently, new key players in the system of thyroid hormone action were detected, like specific transporters for uptake of thyroid hormones and thyroid hormone derivatives. DFG, the German Research Foundation supports the priority program Thyroid Trans Act to find answers to the main question: what defines the healthy thyroid status of an individual. The overall aim of this interdisciplinary research consortium is to specify physiological and pathophysiological functions of thyroid hormone transporters and thyroid hormone derivative as new players in thyroid regulation in order to better evaluate, treat, and prevent thyroid-related disease.

Schlüsselwörter

Schilddrüsenhormonwirkung - Schilddrüsenhormontransporter - Thyronamine

Keywords

thyroid hormone action - thyroid hormone transporters - thyronamines

• Literatur

• 1 Angelico M, De Sanctis SC, Gandin C et al. Spontaneous formation of pigmentary precipitates in bile salt-depleted rat bile and its prevention by micelle-forming bile salts. Gastroenterology 1990; 98: 444-453
• 2 Atzmon G, Barzilai N, Hollowell JG et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009; 94: 1251-1254
• 3 Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 2009; 8: 308-320
• 4 Bianco AC, Anderson G, Forrest D et al. American Thyroid Association Guide to Investigating Thyroid Hormone Economy and Action in Rodent and Cell Models. Thyroid 2013; DOI: 10.1089/thy.2013.0109.
• 5 Biondi B. The normal TSH reference range: what has changed in the last decade?. J Clin Endocrinol Metab 2013; 98: 3584-3587
• 6 Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29: 76-131
• 7 Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011; 21: 5-11
• 8 Braulke L, Klingenspor M, DeBarber A et al. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology 2008; 178: 167-177
• 9 Braun D, Kim TD, le Coutre P et al. Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport. J Clin Endocrinol Metab 2012; 97: E100-105
• 10 Bremner AP, Feddema P, Leedman PJ et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97: 1554-1562
• 11 Brix K, Fuhrer D, Biebermann H. Molecules important for thyroid hormone synthesis and action – known facts and future perspectives. Thyroid Res 2011; 4 (Suppl. 01) S9
• 12 Friesema EC, Grueters A, Biebermann H et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004; 364: 1435-1437
• 13 Garber JR, Cobin RH, Gharib H et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 18: 988-1028
• 14 Gartner R. [Is iodine deficiency still relevant?]. MMW Fortschritte der Medizin 2007; 149: 29-32
• 15 Gencer B, Collet TH, Virgini V et al. Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets 2013; 13: 4-12
• 16 Grasselli E, Voci A, Canesi L et al. Direct effects of iodothyronines on excess fat storage in rat hepatocytes. J Hepatol 2011; 54: 1230-1236
• 17 Heuer H, Visser TJ. The pathophysiological consequences of thyroid hormone transporter deficiencies: Insights from mouse models. Biochim Biophys Acta 2013; 1830: 3974-3978
• 18 Kinne A, Schulein R, Krause G. Primary and secondary thyroid hormone transporters. Thyroid research 2011; 4 (Suppl. 01) S7
• 19 Kohrle J, Gartner R. Selenium and thyroid. Best practice & research Clinical endocrinology & metabolism 2009; 23: 815-827
• 20 Lee JY, Takahashi N, Yasubuchi M et al. Triiodothyronine induces UCP-1 expression and mitochondrial biogenesis in human adipocytes. Am J Physiol Cell Physiol 2012; 302: C463-472
• 21 McNeely PM, Naranjo AN, Robinson AS. Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics. Biotechnol J 2012; 7: 1451-1461
• 22 Meisinger C, Ittermann T, Wallaschofski H et al. Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur J Endocrinol 2012; 167: 363-371
• 23 Moeller LC, Fuhrer D. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer 2013; 20: R19-29
• 24 Moreno M, Silvestri E, De Matteis R et al. 3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J 2011; 25: 3312-3324
• 25 Nader NS, Bahn RS, Johnson MD et al. Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. Thyroid 2010; 20: 1333-1339
• 26 Panas HN, Lynch LJ, Vallender EJ et al. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. J Neurosci Res 2010; 88: 1962-1969
• 27 Panicker V, Wilson SG, Spector TD et al. Genetic loci linked to pituitary-thyroid axis set points: a genome-wide scan of a large twin cohort. J Clin Endocrinol Metab 2008; 93: 3519-3523
• 28 Piehl S, Hoefig CS, Scanlan TS et al. Thyronamines – past, present, and future. Endocr Rev 2011; 32: 64-80
• 29 Porcu E, Medici M, Pistis G et al. A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet 2013; 9: e1003266
• 30 Regard JB, Kataoka H, Cano DA et al. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 2007; 117: 4034-4043
• 31 Rodondi N, den Elzen WP, Bauer DC et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-1374
• 32 Scanlan TS, Suchland KL, Hart ME et al. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004; 10: 638-642
• 33 Surks MI. TSH reference limits: new concepts and implications for diagnosis of subclinical hypothyroidism. Endocr Pract 2013; 1-13 DOI: 10.4158/EP13246.CO.
• 34 Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 4575-4582
• 35 Tabatabaie V, Surks MI. The aging thyroid. Curr Opin Endocrinol Diabetes Obes 2013; 20: 455-459
• 36 Vadiveloo T, Donnan PT, Murphy MJ et al. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab 2013; 98: 1147-1153
• 37 Visser WE, Friesema EC, Visser TJ. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 2011; 25: 1-14
• 38 Walsh JP, Bremner AP, Bulsara MK et al. Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol (Oxf) 2006; 65: 486-491
• 39 Yard EE, Terrell ML, Hunt DR et al. Incidence of thyroid disease following exposure to polybrominated biphenyls and polychlorinated biphenyls, Michigan, 1974-2006. Chemosphere 2011; 84: 863-868
• 40 Burkhardt K, Ittermann T, Heier M et al. TSH-Referenzbereich bei süddeutschen Erwachsenen: Ergebnisse aus der bevölkerungsbasierten KORA F4-Studie. Dtsch med Wochenschr 2014; 139: 317-322